We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPRT:NASDAQOportun Financial Corporation Analysis

Data as of 2026-04-22 - not real-time

$5.74

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Oportun Financial (OPRT) is trading at $5.74, well below its DCF‑derived fair value of $59.05, implying an upside of roughly 38% and positioning the stock as significantly undervalued. The technical picture is mixed: the 20‑day SMA ($5.02) sits just above the 50‑day SMA ($4.98) while both remain below the 200‑day SMA ($5.55), suggesting a neutral longer‑term trend, yet the MACD histogram is positive (0.12) and the MACD line ($0.25) exceeds its signal ($0.13), delivering a bullish signal. Momentum remains strong with an RSI of 67, indicating continued buying pressure but approaching overbought territory.
Recent earnings highlight a turnaround: the company posted GAAP EPS of $0.53 for 2025 and an adjusted EPS of $1.36, an 89% YoY increase, alongside a gross margin of 95% and operating margin of 10.7%. Leadership has shifted to interim co‑CEOs Kate Layton and Gaurav Rana, introducing short‑term governance uncertainty but also an opportunity for strategic realignment. Despite a high beta (~2.1) and 30‑day volatility near 60%, volume remains stable, and the balance sheet shows ample cash ($104M) against a large debt load, resulting in a very high debt‑to‑equity ratio. Overall, the combination of deep valuation discount, recent profitability, and bullish technical cues outweighs the heightened risk profile.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • RSI indicating strong momentum
  • Current price above short‑term support (≈$4.33)

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained GAAP profitability and EPS growth
  • Significant valuation gap to DCF fair value
  • Strategic expense reductions improving margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term undervaluation with 38% upside potential
  • Mission‑driven niche in credit services with high gross margins
  • Potential for leadership stabilization and strategic growth

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin3.48%
P/E Ratio10.8
ROE6.79%
ROA0.78%
Debt/Equity720.61
P/B Ratio0.7
Op. Cash Flow$413.4M
Industry P/E17.6

Technical Analysis

TrendNeutral
RSI67.6
Support$4.33
Resistance$6.14
MA 20$5.02
MA 50$4.98
MA 200$5.55
MACDBullish
VolumeStable
Fear & Greed Index86.96

Valuation

Fair Value$59.05
Target Price$7.92
Upside/Downside37.92%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.08
Volatility59.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.